Saturn V Capital Management as of Dec. 31, 2022
Portfolio Holdings for Saturn V Capital Management
Saturn V Capital Management holds 19 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Crinetics Pharmaceuticals In Common (CRNX) | 9.4 | $11M | 624k | 18.17 | |
| 2seventy Bio Common | 8.2 | $9.9M | 685k | 14.43 | |
| Apellis Pharmaceuticals Common | 7.8 | $9.4M | 212k | 44.34 | |
| Arcutis Biotherapeutics Common (ARQT) | 7.3 | $8.8M | 487k | 18.04 | |
| Cytokinetics Common (CYTK) | 6.6 | $8.0M | 197k | 40.48 | |
| Ascendis Pharma A/s Sponsored ADR | 6.6 | $8.0M | 68k | 116.28 | |
| Morphic Hldg Common (MORF) | 6.1 | $7.4M | 270k | 27.33 | |
| Iteos Therapeutics Common | 5.8 | $7.0M | 342k | 20.55 | |
| Albireo Pharma Common | 5.7 | $6.9M | 342k | 20.08 | |
| Chinook Therapeutics Common | 5.6 | $6.7M | 423k | 15.90 | |
| Kalvista Pharmaceuticals Common | 5.6 | $6.7M | 720k | 9.30 | |
| Cymabay Therapeutics Common | 4.7 | $5.7M | 1.6M | 3.55 | |
| Horizon Therapeutics SHS | 4.7 | $5.7M | 69k | 82.13 | |
| Sage Therapeutics Common (SAGE) | 4.5 | $5.4M | 156k | 34.39 | |
| Amicus Therapeutics Common (FOLD) | 4.1 | $4.9M | 566k | 8.64 | |
| Biocryst Pharmaceuticals Common (BCRX) | 3.1 | $3.8M | 340k | 11.03 | |
| Biogen Common (BIIB) | 1.8 | $2.2M | 7.7k | 283.29 | |
| Astria Therapeutics Common | 1.3 | $1.6M | 170k | 9.18 | |
| Theravance Biopharma Common (TBPH) | 1.1 | $1.3M | 141k | 9.44 |
